Salary for diabetes contract ong/kxr

Quote






Anonymous said:
Could you share how much more in bonus you received? Newly hired reps were basically hired, trained via online (which half the time DIDN'T WORK!!), had to learn 3 products within one week, and then travel to the boonies in a snowstorm of which some of us couldn't make due to a blizzard!! No way I'd leave my state for training they could've easily postponed until AFTER THE STORM! This was by far the most unorganized training I've had!
Click to expand...


Welcome to Publicsis! This is our reality, you just have to live in it.
 






I thought the same thing throughout training. Why on earth would they insist on having us risk traveling for a 2 day training in the middle of nowhere! And btw it was in no shape or form 'TRAINING'!!!! No one taught us jack while we were there. No training on how to use resources, ipads, etc etc etc. It was basically 'Here's your detail piece now go in there and show us the million things you learned this past week!!' WTF?! IS THIS EVEN LEGAL??!! You couldn't get away with this in a real pharma company!
 






Anonymous said:
If you are not happy with the salary - don't apply or accept if offered. This is a contract company, not a manufacturer - If you are so interrested in AZ - go work for them. I am sure there are plently of out of work reps who would be more than happy with this salary range.
Click to expand...

I agree totally. Yes this wasnt what I thought I was worth, but it was better than being without a job. I know many friends from Novartis who would tear your arm off for the contract. In short, take it, work just enough and find something else. I must say though, comming from a large pharma company of 10 years, I do love not having someone up your ass every ten minutes, no programs, etc. For the time being it is worth it
 












Guess I'm not the only one who thought the same. Not one person has an advanced degree in Science or an MBA, or enough experience, yet leading the Publicis wagon. This show would be shut down quick if it were another drug company. We had ours a few weeks ago and it was a complete fiasco!
 




























































I am not going to hold my breath that this will be extended since ong/kxr is tanking everywhere. It's the money maker and farxiga is good replacement for dpp4 if their kidneys are good. I have started looking now. I need a job, so I will leave early w/ a job in place before i'm laid off here.
 






Anonymous said:
I am not going to hold my breath that this will be extended since ong/kxr is tanking everywhere. It's the money maker and farxiga is good replacement for dpp4 if their kidneys are good. I have started looking now. I need a job, so I will leave early w/ a job in place before i'm laid off here.
Click to expand...

I will not be too surprised if they give Ong/KXR back to one of DS1, 2, or 3 pretty soon. A lot of us DS4 are really good, experienced reps but don't have as good relationships as some of the AZ/BMS reps who launched Onglyza. But I also think they will extend the DS4 contract, as there is so much competitive DPP4 noise in the market place and they really need DS4, Summit, and a direct rep.
 






By Ed Silverman

The pharmaceutical industry has shed thousands of sales representatives over the past decade, but drug makers continue to invest in hiring and training, albeit at rates that are only slightly higher than what was seen several years ago. The upshot is that the demise of these marketing stalwarts may have been exaggerated.

Among U.S. drug makers, the annual cost per primary care rep ranges from $125,000 to $200,000, although most companies allocate roughly $160,000, which is up from $150,000 back in 2005. The modest increase reflects less travel, fewer extravagant meetings and lower costs for laptops and tablets, according to a recent report by Cutting Edge Information, a market research firm.

The same factors helped temper cost for reps who call on specialist physicians and hospitals, although the averages were, not surprisingly, higher than for primary care reps. The average cost for a specialty rep was $228,000, while the average annual cost for hospital reps was $243,000, according to the report, which queried 61 drug and seven device makers late last year.

Although the industry shed 40,000 reps between 2006 and early 2013, according to ZS Associates, a sales consultant to drug makers, reps remain a primary vehicle to reach physicians with product information. Drug makers increasingly use technology – from emailing materials to informational webinars – to interact with physicians. But reps continues to fill an important role in distributing medical research and samples of products– a process known in the industry as “detailing.”

“The reps are still very much needed to talk to physicians,” says Christie Shilling, a Cutting Edge research analyst. “I think the ratio of reps to physicians is dropping from 4-to-1 to nearly 1-to-1, and the nature of the interactions is going to change. Their responsibilities are going to become more like relationship managers.”

Drilling down, the average cost of making a sales call to a primary care physician, with samples, was $210, compared with $178 without samples. But costs ranged from $50 to $500, underscoring differences among therapeutic categories and medicines. To visit a specialist, the average cost with samples was $285, but $267 without samples. And the average cost of a hospital visit was $260, which fell to $228 without samples.

Interestingly, an average of only 10% of all interactions are spent using the Internet or mobile device to host webinars or interact with physicians by email. The vast majority of physician outreach efforts continue to be undertaken through traditional methods – a face-to-face encounter with doctors. In any event, the average annual investment in electronic methods is $1.96 million.

Overall, sales rep compensation consumes a varying portion of budgets for sales efforts, ranging anywhere from 30 percent to 70 percent. Samples, however, cost drug makers between 2 percent and 6 percent of budgets, on average, while training for newly hired sales reps cost between 5 percent and 8 percent. Specifically, the average cost of training primary care sales reps is about $18,300, but $20,500 for specialty and nearly $21,900 for hospital reps.

But how much do reps make? Compensation levels have largely remained unchanged in recent years. On average, primary care reps make $96,000, while the highest-paid received $129,000. Incentive pay made up about one-quarter of compensation, but high-performing reps derived 30 percent from bonuses.

The average total compensation for a U.S. primary care district manager was $142,000, and $168,000 for a specialty sales manager, while district managers overseeing hospital reps received $186,000 (this included device makers). For regional managers, the average total compensation was between $180,000 and $250,000. Among those overseeing primary care reps, the average compensation was $204,000, which climbed to $220,000, for specialty regional managers and $229,000 for hospital regional managers.
 






Anonymous said:
I will not be too surprised if they give Ong/KXR back to one of DS1, 2, or 3 pretty soon. A lot of us DS4 are really good, experienced reps but don't have as good relationships as some of the AZ/BMS reps who launched Onglyza. But I also think they will extend the DS4 contract, as there is so much competitive DPP4 noise in the market place and they really need DS4, Summit, and a direct rep.
Click to expand...

They need SUMMIT? HAHAHAHAHAHAHAHAH The Ong/KXR numbers are worse since they got here. The Summit DM's and reps are bottom of the barrel. Publicis should be embarrassed by that motley group. You can only go so cheap before you end up with shit!
 






The salary is beat down by the fact that the recruiting manager is qualified as a MA to make $13.-$15. per hour. Thus, she states that 50-60K is a lot of money. She hates drug reps.
 






Top Bottom
Back
Quote